glp-1 agonist common side effects TrimRX Safety and Tolerability of Glucagon-Like

Description

Whilst such trials are required to ensure medically appropriate adoption of the drug class in HF, they are also strongly warranted considering the current scarcity of pharmacotherapeutic options in HF (especially HFpEF), which remains one of the CVDs with markedly unaddressed medical needs

Increasing the dose slowly over time helps to minimize the frequency and severity of GI symptoms

Patients will first need prior authorization -- prescribing clinicians will submit documentation proving the patient meets strict body mass index (BMI) and health condition requirements

doi: 10.1007/s00259-012-2198-5

No significant difference was noted between GLP-1 RA and placebo groups with respect to gastric emptying measured via the acetaminophen absorption test ( p = 0.432)